WO2001053284A1 - Process for the preparation of 5-carboxyphthalide and its use for the production of citalopram - Google Patents
Process for the preparation of 5-carboxyphthalide and its use for the production of citalopram Download PDFInfo
- Publication number
- WO2001053284A1 WO2001053284A1 PCT/EP2001/000617 EP0100617W WO0153284A1 WO 2001053284 A1 WO2001053284 A1 WO 2001053284A1 EP 0100617 W EP0100617 W EP 0100617W WO 0153284 A1 WO0153284 A1 WO 0153284A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- process according
- carboxyphthalide
- acid
- mixture
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- BGJSXRVXTHVRSN-UHFFFAOYSA-N C1OCOCO1 Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
Definitions
- the present invention concerns a process for the preparation of an isobenzofuran derivative. More particularly, the invention refers to a process for the preparation of 1-oxo-l, 3-dihydro-5- 5 isobenzofurancarboxylic acid.
- 5- 15 carboxyphthalide is an intermediate useful in the synthesis of citalopram, a well-known antidepressant drug, whose preparation using said intermediate is described in the International Patent Application WO 00023431 and in the corresponding Italian Patent Application IT1999 MI 0001724, whose contents must be considered 20 as integral part of the present description.
- 5-carboxyphthalide may be prepared by reduction of one of the carbonyl groups of trimellitic anhydride, which can occur by hydrogenation or, according to DE-2630927, by electrochemical reduction.
- This method has the drawback of giving 25 a 5-carboxyphthalide containing, as a by-product, the 6 isomer in an amount which can reach 10%.
- An impurity which is present in such a percent cannot be accepted if 5-carboxyphthalide must be used as an intermediate in the preparation of drugs and, in such a case, it must be removed or strongly reduced to a value not higher 30 than 0.1%. The removal of the 6 isomer occurs by several crystallizations which lower the yield in final product considerably .
- 5-carboxyphthalide may be prepared according to another method, described in US 3,607,884, which
- the present invention provides, according to a method of simple execution, a process for the preparation of 5- carboxyphthalide of formula A, which comprises adding terephthalic acid of formula I
- formaldehyde is used in one of its solid forms, currently in form of its precursor 1, 3 , 5-trioxane of formula II
- the fuming sulfuric acid which represents the reaction medium, also is the dehydrating agent which allows the direct transformation, in situ, of the 2-hydroxymethylterephthalic acid thus obtained of formula III
- terephthalic acid is added to fuming sulfuric acid, currently containing at least by weight 20%, advantageously 22 ⁇ 33%, preferably 25 ⁇ 30% by weight of S ⁇ 3 , then the mixture thus obtained is treated with 1, 3 , 5-trioxane at a temperature of 30 ⁇ 35°C and subsequently heated at a temperature of 120 ⁇ 145°C, preferably at 130 ⁇ 135°C.
- the temperature is brought to 130 ⁇ 145°C and, after a 2 ⁇ 5-hour heating at this temperature, there is formed compound III which concurrently dehydrates to give 5-carboxyphthalide.
- the preferably used amount of fuming sulfuric acid containing 25 ⁇ 30% by weight in S0 3 is 2 ⁇ 8 1/Kg of terephthalic acid, advantageously 2 ⁇ 6 1/Kg, preferably 3 ⁇ 6 1/Kg, particularly about 3 1/kg.
- the mixture when the reaction is over, the mixture may be poured into ice, by anyhow controlling the exothermia of this operation, and the strong acidity of the medium may be neutralized with a base, preferably sodium, hydroxide, carbonate or bicarbonate .
- a base preferably sodium, hydroxide, carbonate or bicarbonate .
- the mixture in sulfuric acid may also at first be diluted with glacial acetic acid and then treated with water.
- the mixture is diluted with glacial acetic acid in an amount of 200 ml per 100 g of terephthalic acid, by letting the temperature to rise to 20 ⁇ 25°C at the end of the addition. Successively the water is added and, under external cooling, the temperature may rise to 45 °C. Finally, the mixture is neutralized with a base, as set forth above.
- the isolation steps during the addition of the base, it may be suitable to reach a pH ⁇ 8, whereby the 5-carboxyphthalide is present in the solution as a salt, advantageously of an alkali metal, preferably of sodium, and to filter off the insoluble products whilst the 5-carboxyphthalide salt remains dissolved in the medium.
- a neutral filter aid for example Celite" or Dicalite ® .
- the 5- carboxyphthalide free acid may be easily recovered in good yields from the solution containing its salt by neutralization with an acid, for example with hydrochloric acid, and isolated in sufficiently pure form for its use as intermediate for the preparation of drugs.
- the 5-carboxyphthalide precipitates at acid pH at a value of about 3, preferably in the range of 1.8 ⁇ 3.0, and is isolated by simple filtration.
- the isolation steps through the salt preferably with an alkaline metal, it is suitable to maintain the pH value not higher than 8 in order to avoid the formation of by-products.
- the alkaline agent it is suitable to control the pH changes when a value of about 5 is reached, because around this value it is possible that small additions of base involve considerable pH variations .
- the mixture may be treated by dropping water thereinto, so that said water initially destroys any possible residual S0 3 and then dilutes sulfuric acid progressively thus rendering the isolation of 5-carboxyphthalide easier.
- the addition of water, which produces exothermia, is preferably made at a temperature of 0 ⁇ 5°C.
- the control of the temperature may be limited to the initial period of the addition of 10 ⁇ 15% of water (in respect of the used fuming sulfuric acid); afterwards, particular care are not necessary because the temperature of the mixture remains at about 20 ⁇ 25°C and, hence, it may be easily controlled.
- the 5-carboxy phthalide may be isolated by simple filtration, by washing with water, if necessary by triturating the obtained product in water.
- the mixture is heated to 120°C and it is noted that, already at
- the solid is removed by filtration on Dicalite in a buchner and washed with water.
- the solid is filtered, washed 3 times with 500 ml of deionized water at 40°C and suspended in 1000 ml of deionized water.
- the suspension is heated under stirring at 50 ⁇ 55°C and kept 1 hour under these conditions, then it is hot filtered.
- the solid is washed with deionized water and dried in vacuo at 50 °C to constant weight.
- 180 g of light-brown coloured 5- carboxyphthalide with a purity (HPLC) > 95% are obtained.
- the mixture is nevertheless heated to 130 ⁇ 135°C and kept 4 hours under these conditions.
- the cooled mixture is poured, in about 1 hour and without exceeding the temperature of 25 ⁇ 35°C, into 3000 g of crushed ice.
- 300 ml of 5% w/w solution of sodium hydroxide are added to the mixture to a pH __ 8.
- the solid is
- the mixture is let to stand 60 minutes under stirring at 20 ⁇ 25°C and filtered.
- the wet product is suspended in 1900 ml of water.
- the suspension is heated up to 25 ⁇ 30°C under stirring, its pH is adjusted to about 8 by gradual addition of 175 g of sodium bicarbonate.
- the solid is filtered off
- the mass is cooled to -5 ⁇ 0°C and 1800 ml of cold deionized water are added thereto. During this operation the temperature rises to 43 ⁇ 45°C. At the end of the addition, the mixture is kept 1 hour under stirring at 23 ⁇ 25°C, then it is filtered, the solid is washed with deionized water abundantly and suspended, still wet, in 1200 ml of deionized water at room temperature. To the suspension thus obtained, about 1550 g of a 7% solution of NaHC0 3 are added to a constant pH of 7,6 ⁇ 7,8.
- the mixture is kept 1 hour under stirring at 20 ⁇ 25°C, the product thus obtained is filtered, still moist triturated in 300 ml of water repeatedly until the reddish colour of the mother liquors disappears. After the third trituration, the pH of the mother liquors stabilizes at values ranging from 5 to 6.
- the product is dried in vacuo at 45 ⁇ 50°C until constant weight to give 47.5 g of 5-carboxyphthalide with a titer and a purity (HPLC) > 95%.
- EXAMPLE 6 In a 3000-1 glass lined reactor, 550 Kg of oleum containing 25% of S0 3 are charged under vacuum and good aspiration, then, consecutively, under stirring, 56 Kg of terephthalic acid at 20 ⁇ 23°C and 26 Kg of 1 , 3 , 5-trioxane at 15 ⁇ 20°C are added thereinto. The reactor is heated at 130 ⁇ 133°C for 4 hours, then the mixture is cooled to 20 ⁇ 23°C and 118 Kg of glacial acetic acid are couled portionwise thereinto at a temperature not higher than 25 °C. At the end of this operation, 1000 Kg of water are added portionwise, whereby the temperature is maintained not higher than 43 ⁇ 45°C by circulation of water in the jacket.
- the mixture is stirred for about 1 hour at 20 ⁇ 23°C, then the product is centrifugated, squeezed and abundantly washed with water in order to remove the larger amount of sulfuric acid from the mother liquors and to obtain 100 ⁇ 105 Kg of 5-carboxyphthalide as a well squeezed, wet raw-product.
- the product thus obtained is suspended in 680 Kg of deionized water and a solution of 60 Kg of sodium bicarbonate in 540 Kg of deionized water is then slowly added to said suspension to a pH of
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Seasonings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU26798/01A AU779581B2 (en) | 2000-01-18 | 2001-01-17 | Process for the preparation of 5-carboxyphthalide and its use for the production of citalopram |
| PL01356563A PL356563A1 (en) | 2000-01-18 | 2001-01-17 | Process for the preparation of 5-carboxyphthalide and its use for the production of citalopram |
| HU0204187A HUP0204187A3 (en) | 2000-01-18 | 2001-01-17 | Process for the preparation of 1-oxo-1,3-dihydro-5-isobenzofurancarboxylic acid and its use for the production of citalopram |
| BR0107853-4A BR0107853A (pt) | 2000-01-18 | 2001-01-17 | Processo para a preparação de 5-carboxiftalida e seu uso para a produção de citalopram |
| EP01901181A EP1187822A1 (en) | 2000-01-18 | 2001-01-17 | Process for the preparation of 5-carboxphthalide and its use for the production of citalopram |
| ROA200200989A RO121737B1 (ro) | 2000-01-18 | 2001-01-17 | Procedeu de preparare a 5-carboxiftalidei şi utilizarea sa pentru producerea de citalopram |
| MXPA02007031A MXPA02007031A (es) | 2000-01-18 | 2001-01-17 | Proceso para la preparacion de 5-carboxiftaluro y su uso para la produccion de citalopram. |
| CA2397497A CA2397497C (en) | 2000-01-18 | 2001-01-17 | Process for the preparation of 5-carboxyphthalide and its use for the production of citalopram |
| BG106925A BG65763B1 (bg) | 2000-01-18 | 2002-07-16 | Метод за получаване на 5-карбоксифталид и неговото използване за получаване на циталопрам |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000MI000050A IT1317729B1 (it) | 2000-01-18 | 2000-01-18 | Procedimento per la preparazione della 5-carbossiftalide. |
| ITMI2000A000050 | 2000-01-18 | ||
| US09/690,301 US6458973B1 (en) | 2000-01-18 | 2000-10-17 | Process for the preparation of 5-carboxyphthalide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2001053284A1 true WO2001053284A1 (en) | 2001-07-26 |
Family
ID=26332721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2001/000617 Ceased WO2001053284A1 (en) | 2000-01-18 | 2001-01-17 | Process for the preparation of 5-carboxyphthalide and its use for the production of citalopram |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US6458973B1 (https=) |
| EP (2) | EP1118614B2 (https=) |
| JP (1) | JP4558182B2 (https=) |
| CN (1) | CN1184220C (https=) |
| AT (1) | ATE219489T1 (https=) |
| AU (1) | AU779581B2 (https=) |
| BG (1) | BG65763B1 (https=) |
| BR (1) | BR0107853A (https=) |
| CA (1) | CA2397497C (https=) |
| DE (1) | DE60000226T3 (https=) |
| DK (1) | DK1118614T4 (https=) |
| ES (1) | ES2178626T5 (https=) |
| HK (1) | HK1042290B (https=) |
| HU (1) | HUP0204187A3 (https=) |
| IT (1) | IT1317729B1 (https=) |
| MX (1) | MXPA02007031A (https=) |
| PL (1) | PL356563A1 (https=) |
| PT (1) | PT1118614E (https=) |
| RO (1) | RO121737B1 (https=) |
| WO (1) | WO2001053284A1 (https=) |
| ZA (1) | ZA200205475B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR026063A1 (es) * | 1999-11-01 | 2002-12-26 | Lundbeck & Co As H | Metodo para la preparacion de 5-carboxiftalida. |
| IES20010157A2 (en) | 2000-03-03 | 2002-03-06 | Lundbeck & Co As H | Method for the preparation of citalopram |
| GB0005477D0 (en) | 2000-03-07 | 2000-04-26 | Resolution Chemicals Limited | Process for the preparation of citalopram |
| CN1427835A (zh) * | 2000-03-13 | 2003-07-02 | H·隆德贝克有限公司 | 5-取代的1-(4-氟苯基)-1,3-二氢异苯并呋喃的分步烷基化 |
| AR032455A1 (es) | 2000-05-12 | 2003-11-12 | Lundbeck & Co As H | Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva |
| US7687645B2 (en) * | 2003-03-21 | 2010-03-30 | H. Lundbeck A/S | Intermediates for the preparation of citalopram and escitalopram |
| US20050154052A1 (en) * | 2003-03-24 | 2005-07-14 | Hetero Drugs Limited | Novel crystalline forms of (s)-citalopram oxalate |
| CN100569765C (zh) | 2003-12-19 | 2009-12-16 | 杭州民生药业集团有限公司 | 西酞普兰中间体晶体碱 |
| WO2006090409A1 (en) * | 2005-02-28 | 2006-08-31 | Kekule Pharma Ltd., | An improved process for the preparation of 5 - carboxyphthalide |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3607884A (en) * | 1969-03-11 | 1971-09-21 | Mobil Oil Corp | Preparation of 5-carboxyphthalide in liquid sodium trioxide |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3976751A (en) † | 1974-10-21 | 1976-08-24 | Allied Chemical Corporation | Stabilization of liquid sulfur trioxide |
| DE2630927A1 (de) | 1976-07-09 | 1978-01-19 | Basf Ag | Verfahren zur herstellung von phthalidcarbonsaeure-(5) |
| DE3605716A1 (de) | 1986-02-22 | 1987-09-03 | Henkel Kgaa | Verwendung von unloeslichen schmutzsammlern zur regenerierung von wasch- und reinigungsloesungen |
| WO1998019513A2 (en) * | 1997-07-08 | 1998-05-14 | H. Lundbeck A/S | Method for the preparation of citalopram |
| CA2291134C (en) * | 1998-10-20 | 2006-05-23 | H. Lundbeck A/S | Method for the preparation of citalopram |
| AR026063A1 (es) * | 1999-11-01 | 2002-12-26 | Lundbeck & Co As H | Metodo para la preparacion de 5-carboxiftalida. |
| AU1130901A (en) | 1999-11-01 | 2001-05-14 | H. Lundbeck A/S | Method for the preparation of 5-carboxyphthalide |
| GB0005477D0 (en) | 2000-03-07 | 2000-04-26 | Resolution Chemicals Limited | Process for the preparation of citalopram |
-
2000
- 2000-01-18 IT IT2000MI000050A patent/IT1317729B1/it active
- 2000-10-17 DK DK00203602.8T patent/DK1118614T4/da active
- 2000-10-17 US US09/690,301 patent/US6458973B1/en not_active Expired - Fee Related
- 2000-10-17 ES ES00203602T patent/ES2178626T5/es not_active Expired - Lifetime
- 2000-10-17 DE DE60000226T patent/DE60000226T3/de not_active Expired - Lifetime
- 2000-10-17 EP EP00203602A patent/EP1118614B2/en not_active Expired - Lifetime
- 2000-10-17 AT AT00203602T patent/ATE219489T1/de not_active IP Right Cessation
- 2000-10-17 PT PT00203602T patent/PT1118614E/pt unknown
- 2000-12-07 JP JP2000372224A patent/JP4558182B2/ja not_active Expired - Lifetime
-
2001
- 2001-01-17 CN CNB018038484A patent/CN1184220C/zh not_active Expired - Lifetime
- 2001-01-17 CA CA2397497A patent/CA2397497C/en not_active Expired - Fee Related
- 2001-01-17 HU HU0204187A patent/HUP0204187A3/hu unknown
- 2001-01-17 RO ROA200200989A patent/RO121737B1/ro unknown
- 2001-01-17 AU AU26798/01A patent/AU779581B2/en not_active Revoked
- 2001-01-17 PL PL01356563A patent/PL356563A1/xx not_active IP Right Cessation
- 2001-01-17 BR BR0107853-4A patent/BR0107853A/pt not_active Application Discontinuation
- 2001-01-17 WO PCT/EP2001/000617 patent/WO2001053284A1/en not_active Ceased
- 2001-01-17 MX MXPA02007031A patent/MXPA02007031A/es active IP Right Grant
- 2001-01-17 EP EP01901181A patent/EP1187822A1/en not_active Withdrawn
-
2002
- 2002-01-25 HK HK02100631.3A patent/HK1042290B/en not_active IP Right Cessation
- 2002-07-09 ZA ZA200205475A patent/ZA200205475B/xx unknown
- 2002-07-16 BG BG106925A patent/BG65763B1/bg unknown
- 2002-08-23 US US10/227,038 patent/US6703516B2/en not_active Expired - Fee Related
-
2004
- 2004-03-08 US US10/796,336 patent/US20040171851A1/en not_active Abandoned
-
2007
- 2007-10-22 US US11/975,842 patent/US20080249319A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3607884A (en) * | 1969-03-11 | 1971-09-21 | Mobil Oil Corp | Preparation of 5-carboxyphthalide in liquid sodium trioxide |
Non-Patent Citations (3)
| Title |
|---|
| BIGLER A J ET AL: "QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS IN A SERIES OF SELECTIVE 5-HT UPTAKE INHIBITORS", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY.CHIMICA THERAPEUTICA,EDITIONS SCIENTIFIQUE ELSEVIER, PARIS,FR, vol. 12, no. 3, May 1977 (1977-05-01), pages 289 - 295, XP000944915, ISSN: 0223-5234 * |
| FORNEY, LEROY S. ET AL: "Reaction of formaldehyde with deactivated benzoic acids. An ester-directed electrophilic aromatic substitution process", J. ORG. CHEM. (1971), 36(5), 689-93, XP002145376 * |
| FORNEY, LEROY S.: "Reaction of terephthalic acid with formaldehyde in sulfur trioxide media", J. ORG. CHEM. (1970), 35(5), 1695-6, XP002145377 * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20080249319A1 (en) | Process for the preparation of 5-Carboxyphthalide | |
| NO177142B (no) | Fremgangsmåte for fremstilling av höyrent 2-fenyl-1,2-benzisoselenazol-3(2H)-on (ebselen) | |
| US6008381A (en) | Process for preparing 3-isochromanone | |
| EP0669310B1 (en) | Processes for producing tetrafluorophthalic anhydride | |
| EP0359438B1 (en) | Pyridazinone manufacture | |
| KR100730623B1 (ko) | 5-카복시프탈리드의 제조방법 및 시탈로프람의 생성을위한 그것의 사용 | |
| CN101506141A (zh) | 2-(4-甲氧基羰基甲基苯氧基甲基)苯甲酸甲酯及其制造方法 | |
| US4264500A (en) | Process of making 6-chloro-α-methyl-carbazole-2-acetic acid | |
| RU2227137C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ α, α-ДИМЕТИЛФЕНИЛУКСУСНОЙ КИСЛОТЫ ИЗ α, α-ДИМЕТИЛБЕНЗИЛЦИАНИДА БЕЗ ДАВЛЕНИЯ | |
| US4127607A (en) | Process for the preparation of an acetamide derivative | |
| RU1811529C (ru) | Способ получени 3-изопропил-бензо-2-тио-1,3-диазинон-(4)-2,2-диоксида | |
| JP3105367B2 (ja) | 4−(1−イミダゾリルメチル)ケイ皮酸の製造方法 | |
| RU2098412C1 (ru) | Способ получения гидрохлорида этилового эфира 10-(3-диэтиламинопропионил)фенотиазинкарбаминовой-2 кислоты | |
| RU2053217C1 (ru) | Способ получения 5-хлорсалициловой кислоты | |
| JPH07196610A (ja) | 5−クロロ−2−オキシンドールの製造法 | |
| KR100898099B1 (ko) | 잘토프로펜의 제조방법 | |
| SU1721051A1 (ru) | Способ получени 2-галоидпроизводных фурана | |
| JPS6011022B2 (ja) | 1−(3,5−ジメトキシ−4−ヒドロキシ)フエニル−2−(n−メチル)アミノ−エタノ−ルの塩酸塩の製造法 | |
| JPH03275641A (ja) | ヒドロキシビフェニル化合物及びその製造法 | |
| JP2001512467A (ja) | 3−[2−クロロ−4−(トリフルオロメチル)フェノキシ]安息香酸の単離方法 | |
| MXPA01002614A (en) | METHOD FOR PRESSURELESS PRODUCTION OF&agr;,&agr;-DIMETHYLPHENYL ACETIC ACID FROM&agr;,&agr;-DIMETHYL BENZYL CYANIDE | |
| HU180688B (hu) | Módosított eljárás 6-fenil-acetamido-2,2-dimetil- -penam - 3-karbonsav-2- (dimetil- amino) - etil - észter- - hidrojodid előállítására |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 2001901181 Country of ref document: EP |
|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| ENP | Entry into the national phase |
Ref document number: 2002 200200989 Country of ref document: RO Kind code of ref document: A |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| WWP | Wipo information: published in national office |
Ref document number: 2001901181 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 26798/01 Country of ref document: AU |
|
| WWE | Wipo information: entry into national phase |
Ref document number: IN/PCT/2002/905/KOL Country of ref document: IN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2397497 Country of ref document: CA |
|
| ENP | Entry into the national phase |
Ref document number: 2001 106925 Country of ref document: BG Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2002/007031 Country of ref document: MX Ref document number: 1020027009223 Country of ref document: KR Ref document number: 018038484 Country of ref document: CN |
|
| WWP | Wipo information: published in national office |
Ref document number: 1020027009223 Country of ref document: KR |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| WWG | Wipo information: grant in national office |
Ref document number: 26798/01 Country of ref document: AU |